ERBB2 and ovarian carcinoma: Our rate of 42% of the ovarian carcinomas expressing ERBB2 is close to 43–44% reported by Kacinski et al (1992) and Fajac et al (1995), who used similar criteria of positivity as in our study (Table 1).